Back to 
CITADEL ADVISORS LLC
CITADEL ADVISORS LLC
INKT1 quarters
Position history for CITADEL ADVISORS LLC's holdings in MINK THERAPEUTICS INC
Yes. Citadel Advisors holds 15,440 shares of INKT (Mink Therapeutics), worth $180,494, as of its Q2 2026 13F filing. It opened the position in Q2 2026.
Current Value
$180,494
Current Shares
15,440
Total Value Change
$0
Total Shares Change
0
Quarter-by-Quarter History
Other major holders of INKT: VANGUARD CAPITAL MANAGEMENT LLC, VANGUARD GROUP INC, DnB Asset Management AS